Discovering The Potential of Complement Component 1q as A Drug Target

Target Name: Complement component 1q

NCBI ID: P10264

Complement component 1q

Other Name(s): C1q

Discovering The Potential of Complement Component 1q as A Drug Target

Complement component 1q (C1q), also known as activin receptor type 1 (A1R1), is a protein that is expressed in various tissues throughout the body, including the blood, skin, and eyes. It is a member of the complement system, a group of proteins that work together to help the immune system fight off infections.

One of the things that makes C1q an interesting potential drug target is its role in the immune response. As research has shown, C1q plays a key role in the regulation of inflammation and infection.

One of the ways that C1q helps to regulate inflammation is by limiting the activity of immune cells that are involved in the immune response. This is done by interacting with a protein called Fc纬R1, which is also known as CD71.

In addition to its role in limiting the activity of immune cells, C1q has also been shown to help to regulate the production of new immune cells. This is done by interacting with another protein called CSF2, which is involved in the production of white blood cells.

Another potential drug target for C1q is its role in the development and progression of certain diseases. For example, studies have shown that high levels of C1q are associated with an increased risk of developing skin diseases, such as eczema and psoriasis.

In addition to its potential as a drug target, C1q is also of interest to researchers because of its structure and the fact that it is expressed in a wide variety of tissues. This makes it an attractive target for researchers who are looking for new ways to treat a variety of diseases.

Overall, C1q is a protein that has the potential to be a drug target due to its role in the immune response and its association with the development of certain diseases. Further research is needed to fully understand its potential and to develop safe and effective treatments.

Protein Name: Complement Component 1q

The "Complement component 1q Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Complement component 1q comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets